SciSparc Nutraceuticals Granted An Exclusive License For The Sales Of CannAmide On The Amazon Marketplace In Canada
Portfolio Pulse from Vuk Zdinjak
Jeffs' Brands Ltd (NASDAQ:JFBR) announced that SciSparc Nutraceuticals, in which it owns a 49% equity interest, has entered into an exclusive license and distribution agreement to sell and market CannAmide on the Amazon.com marketplace in Canada. The license was granted by SciSparc Ltd. (NASDAQ:SPRC), a clinical-stage pharmaceutical company.
June 07, 2023 | 1:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jeffs' Brands Ltd's subsidiary, SciSparc Nutraceuticals, has secured an exclusive license to sell CannAmide on Amazon in Canada.
The exclusive license to sell CannAmide on Amazon in Canada is a positive development for Jeffs' Brands Ltd, as it expands the company's product offerings and market reach. This could potentially lead to increased sales and revenue for the company, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
SciSparc Ltd. granted an exclusive license to SciSparc Nutraceuticals, a subsidiary of Jeffs' Brands Ltd, to sell CannAmide on Amazon in Canada.
The granting of the exclusive license to sell CannAmide on Amazon in Canada is a positive development for SciSparc Ltd, as it could potentially lead to increased sales and revenue for the company. This could positively impact its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100